Salt sensitivity of blood pressure in non-dialysis patients with chronic kidney disease

Renal Failure

Volumn 36, Issue 3, 2014, Pages 345-350

  Meng, Lin ^a   Fu, Bin ^a   Zhang, Tongyan ^a   Han, Zunmin ^a   Yang, Meijuan ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Blood pressure; Chronic kidney disease; Salt intake; Salt sensitivity

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; POTASSIUM; SODIUM CHLORIDE; SODIUM ION; SODIUM INTAKE;

ADULT; AGE; ANALYTICAL PARAMETERS; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BODY MASS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; DIET; DISEASE ASSOCIATION; EATING HABIT; ELECTROLYTE DISTURBANCE; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; SALT INTAKE; SALT SENSITIVITY; SALT SENSITIVITY INDEX; SODIUM INTAKE; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; ADMINISTRATION AND DOSAGE; AGED; ALBUMINURIA; CHRONIC KIDNEY FAILURE; COMPLICATION; DISEASE COURSE; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; RISK FACTOR; SYSTOLE; URINE;

AGED; ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POTASSIUM; REGRESSION ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SODIUM, DIETARY; SYSTOLE;

EID: 84896484953     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.866008     Document Type: Article

References (23)

1. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis. 2002;39:S1-S266.
2. Sacks FM, Svetkey LP, Vollmer WM, et al. DASH-sodium collaborative research group: effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3-10.
3. Du Bois EF. The measurement of the body surface area in man. Arch Intern Med. 1916;15:868-881.
4. Merlo J, Wessling A, Melander A. Comparison of dose standard units for drug utilization studies. Eur J Clin Pharmacol. 1996;50: 27-30.
5. Xu H. The Clinical Guide to the Chinese Pharmacopoeia. In: China T, Xu H, eds. Tianjin: Tianjin Electronic Press; 2005:464-537, 590-599, 673-710, 953-960.
6. Chen X, Jin Y, Tang G. New Pharmacology. Beijing, China: People's Medical Publishing House; 2007:392-406.
7. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation: National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137-147. (Erratum in 2003;139:605).
8. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med. 2002;346:913-923.
9. Mailloux LU. Hypertension in chronic renal failure and ESRD: prevalence pathophysiology, and outcomes. Semin Nephrol. 2001; 21:146-156.
10. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med. 2002;346:913-923.
11. Franklin SS, Gustin W IV, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308-315.
12. Minawaer Y, Liu J, Reyihan X. Clinical analysis of influential factors on arterial stiffness in early metaphase chronic kidney disease patients. J Xinjiang Med Univ. 2011; 34:733-736.
13. He FJ, Marciniak M, Visagie E, et al. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. Hypertension. 2009;54:482-388.
14. Mercier N, Labat C, Louis H, et al. Sodium, arterial stiffness, and cardiovascular mortality in hypertensive rats. Am J Hypertens. 2007;20:319-325.
15. Yang W, Zhang S, Sun Z, Zhu Y, Zhang S, Sun J. Relationship between the estimated glomerular filtration Rate and bachial-Ankle pulse wave velocity in healthy population. Chin Circul J. 2011;26: 287-290.
16. Miyatake N, Shikata K, Makino H, Numata T. Relationship between the estimated glomerular filtration rate and pulse wave velocity in Japanese. Intern Med. 2010;49:1315-1320.
17. Cianciaruso B, Bellizzi V, Minutolo R, et al. Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab. 1998;24:296-301.
18. Writing group of 2010 Chinese guidelines for the management of hypertension: 2010 Chinese guidelines for the management of hypertension. Chin J Hypertens. 2011;8:701-743.
19. Mancia G, De Backer G, Dominiczak A, et al. Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology: 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187.
20. Chobanian AV, Bakris GL, Black HR, et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
21. Kimura G. Kidney and circadian blood pressure rhythm. Hypertension. 2008;51:827-828.
22. Kimura G. Sodium, kidney, and circadian rhythm of blood pressure. Clin Exp Nephrol. 2001;5:13-18.
23. Fukuda M, Goto N, Kimura G. Hypothesis on renal mechanism of non-dipper pattern of circadian blood pressure rhythm. Med Hyp. 2006;67:802-806.